Robotic Genome Accountability Governance Doctrine

Introduction

The Robotic Genome Accountability Governance Doctrine refers to a proposed legal and regulatory framework that establishes responsibility, supervision, transparency, and ethical standards for robotic systems used in genomic research, genetic testing, and genome editing.

Modern genomic technologies combine robotics, artificial intelligence (AI), and biotechnology to analyse DNA, identify hereditary diseases, and modify genetic material. Although these technologies offer significant benefits in healthcare and scientific research, they also create risks involving genetic privacy, inaccurate diagnosis, unauthorised genome editing, and harm to future generations.

The doctrine seeks to ensure that robotic genomic technologies remain subject to effective legal control. It emphasises that autonomous technological systems cannot replace human responsibility or eliminate the accountability of researchers, manufacturers, healthcare professionals, and regulatory authorities.

Governance Framework in India

India does not formally recognise a separate statutory doctrine called the Robotic Genome Accountability Governance Doctrine. It is a proposed legal concept derived from constitutional rights, biotechnology regulation, environmental protection, and scientific accountability.

The principal legal framework includes:

Environment (Protection) Act, 1986: Provides the statutory foundation for regulating specified genetically engineered organisms.

1989 Biosafety Rules: Establish regulatory oversight of research, manufacture, use, and environmental release of certain genetically engineered organisms.

Article 21: Protects life, personal liberty, and the right to a safe and healthy environment.

Article 14: Requires fairness and non-arbitrariness in governmental regulatory decisions.

Digital Personal Data Protection Act, 2023: Relevant to digital genomic information, subject to its applicable provisions and commencement.

Consumer Protection Act, 2019: May provide remedies for defective genomic equipment and deficient services.

The 1989 Rules establish several regulatory bodies, including the Institutional Biosafety Committee (IBSC), Review Committee on Genetic Manipulation (RCGM), and Genetic Engineering Appraisal Committee (GEAC). These bodies provide institutional supervision and biosafety review for relevant biotechnology activities.

VoxJuris+1

Important Case Laws

1. Gene Campaign v. Union of India (2024), 2024 INSC 545

The Supreme Court examined the regulatory approval of genetically modified mustard, DMH-11. The Court recognised the permissibility of judicial review of decisions concerning genetically modified organisms and directed the formulation of a national policy on GM crops through stakeholder consultation. It also required verification and disclosure of experts' credentials and conflicts of interest.

Indian Kanoon+1

This case is directly relevant to genome governance because it highlights scientific transparency, regulatory accountability, public participation, and biosafety supervision.

2. Justice K.S. Puttaswamy v. Union of India (2017), (2017) 10 SCC 1

The Supreme Court recognised privacy as a fundamental right under Article 21.

This judgment provides a constitutional foundation for protecting genetic information from unlawful collection, disclosure, and misuse. Robotic genomic platforms must respect privacy and individual autonomy.

3. Bhabani Prasad Jena v. Orissa State Commission for Women (2010), (2010) 8 SCC 633

The Supreme Court held that DNA testing should not be ordered routinely in parentage disputes. Courts must balance scientific necessity against privacy, dignity, and family interests.

The case supports responsible governance of automated genetic testing by requiring legal justification for intrusive genomic procedures.

4. Selvi v. State of Karnataka (2010), (2010) 7 SCC 263

The Supreme Court held that involuntary narcoanalysis, polygraph examinations, and brain electrical activation profile tests violate constitutional protections under Articles 20(3) and 21.

The decision supports the principle that scientific technologies must respect personal autonomy. Its application to genomic testing is analogous, rather than a direct ruling on genome editing.

Core Principles of the Doctrine

An effective governance framework should establish:

Mandatory risk assessment before high-risk genomic procedures.

Human supervision of autonomous genome-editing systems.

Informed consent and genetic data protection.

Independent scientific validation and regular audits.

Clear liability for developers, manufacturers, researchers, and institutions.

Public consultation and disclosure of regulatory conflicts of interest.

Effective remedies for persons harmed by genomic technologies.

Conclusion

The Robotic Genome Accountability Governance Doctrine seeks to establish a legally accountable system for robotic genomic research and genetic modification. Although no Indian statute formally recognises this doctrine by name, constitutional jurisprudence and biotechnology regulations provide a foundation for its development.

The judgments in Gene Campaign, Puttaswamy, Bhabani Prasad Jena, and Selvi establish important principles of regulatory transparency, privacy, autonomy, and scientific responsibility.

Ultimately, genomic innovation must remain subject to human oversight, legal accountability, and constitutional protection.